Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial

BACKGROUND: The randomized placebo-controlled IFIGENIA-trial demonstrated that therapy with high-dose N-acetylcysteine (NAC) given for one year, added to prednisone and azathioprine, significantly ameliorates (i.e. slows down) disease progression in terms of vital capacity (VC) (+9%) and diffusing c...

Descripción completa

Detalles Bibliográficos
Autores principales: Behr, Jürgen, Demedts, Maurits, Buhl, Roland, Costabel, Ulrich, Dekhuijzen, Richard PN, Jansen, Henk M, MacNee, William, Thomeer, Michiel, Wallaert, Benoit, Laurent, Francois, Nicholson, Andrew G, Verbeken, Eric K, Verschakelen, Johny, Flower, CDR, Petruzzelli, Stefano, De Vuyst, Paul, Bosch, JMM van den, Rodriguez-Becerra, Eulogio, Lankhorst, Ida, Sardina, Marco, Boissard, Gabrielle
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774307/
https://www.ncbi.nlm.nih.gov/pubmed/19860915
http://dx.doi.org/10.1186/1465-9921-10-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774307/
https://www.ncbi.nlm.nih.gov/pubmed/19860915
http://dx.doi.org/10.1186/1465-9921-10-101

Ejemplares similares